Skip to content

Amgen AMGN Net Income

Net Income at other companies

Eli Lilly logo
Eli LillyLLY
$7.4B+168%
Pfizer logo
PfizerPFE
$2.69B-9.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$44.9M+11.7%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$31.82M-51.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$8.65M-24.4%

Segments

By segment

See full
Reportable Segment$1.82B+5.1%

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$190.42B+22.4%
Enterprise value$247.18B+16.4%
P/E24.4×-1.8×
P/S5.1×+0.6×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp
FCF margin23.1%-8.9pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's net income?
Amgen (AMGN) reported net income of $1.82B in Q1 2026.
How has Amgen's net income changed year-over-year?
Amgen's net income increased by 5.1% year-over-year, from $1.73B to $1.82B.
What is the long-term trend for Amgen's net income?
Over 4 years (2021 to 2025), Amgen's net income has grown at a 7.0% compound annual growth rate (CAGR), from $5.89B to $7.71B.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.